Primary tacrolimus immunosuppression in kidney recipients considered ''higher immunologic risk''

By Braun F.   Lorf T.   Schutz E.   Canelo R.   Hanack U.   Dopkens K.   Sattler B.   Grupp C.   Ringe B.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 2535-2535

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients

By Braun F.   Schutz E.   Peters B.   Talaulicar R.   Grupp C.   Undre N.   Schafer A.   Armstrong V.W.   Oellerich M.   Ringe B.  

Transplantation Proceedings, Vol. 33, Iss. 3, 2001-05 ,pp. : 2127-2128

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of daclizumab induction for primary kidney transplant recipients in combination with tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression

By Ciancio G.   Burke G.W.   Suzart K.   Vaidya A.   Roth D.   Kupin W.   Mattiazzi A.   Rosen A.   Esquenazi V.   Miller J.  

Transplantation Proceedings, Vol. 35, Iss. 2, 2003-03 ,pp. : 873-874

Elsevier

Access to resources Recommend Favorite

Posttransplant diabetes mellitus in kidney transplant recipients under tacrolimus immunosuppression

By Khoury N.   Kriaa F.   Hiesse C.   Von Ey F.   Durbach A.   Ammor M.   Hafi A.   Djeffal R.   Boubenider S.   Droupy S.   Hammoudi Y.   Eschwege P.   Benot G.   Charpentier B.  

Transplantation Proceedings, Vol. 32, Iss. 8, 2000-12 ,pp. : 2763-2764

Elsevier

Access to resources Recommend Favorite

Primary tacrolimus-based immunosuppression in renal allograft recipients: - A single center experience

By Lye W.C.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1700-1701

Elsevier

Access to resources Recommend Favorite